StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) KPIs and segments

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.11−1.13 (-5.58%)

Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Nuvectis Pharma's business

Coming soon

This tab will track the numbers specific to Nuvectis Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?